BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28062693)

  • 21. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R; Théoleyre O; Douablin A; Baklouti F
    Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus.
    Carlsson R; Persson C; Leanderson T
    Mol Immunol; 2003 Jun; 39(16):1035-43. PubMed ID: 12749910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter.
    Ying H; Chang JF; Parnes JR
    J Immunol; 1998 Mar; 160(5):2287-96. PubMed ID: 9498769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription factors PU.1 and IRF4 regulate activation induced cytidine deaminase in chicken B cells.
    Luo H; Tian M
    Mol Immunol; 2010 Apr; 47(7-8):1383-95. PubMed ID: 20299102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
    Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
    Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells.
    Wei F; Zaprazna K; Wang J; Atchison ML
    Mol Cell Biol; 2009 Sep; 29(17):4612-22. PubMed ID: 19564417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c.
    Yashiro T; Kasakura K; Oda Y; Kitamura N; Inoue A; Nakamura S; Yokoyama H; Fukuyama K; Hara M; Ogawa H; Okumura K; Nishiyama M; Nishiyama C
    Int Immunol; 2017 Feb; 29(2):87-94. PubMed ID: 28338898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PU.1 opposes IL-7-dependent proliferation of developing B cells with involvement of the direct target gene bruton tyrosine kinase.
    Christie DA; Xu LS; Turkistany SA; Solomon LA; Li SK; Yim E; Welch I; Bell GI; Hess DA; DeKoter RP
    J Immunol; 2015 Jan; 194(2):595-605. PubMed ID: 25505273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spi-C, a novel Ets protein that is temporally regulated during B lymphocyte development.
    Bemark M; Mårtensson A; Liberg D; Leanderson T
    J Biol Chem; 1999 Apr; 274(15):10259-67. PubMed ID: 10187812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PU.1 binding site is a cis-element that regulates pro-B/pre-B specificity of Vkappa-Jkappa joining.
    Hayashi R; Takemori T; Kodama M; Suzuki M; Tsuboi A; Nagawa F; Sakano H
    J Immunol; 1997 Nov; 159(9):4145-9. PubMed ID: 9379006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
    Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
    Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients.
    Le Coz C; Nguyen DN; Su C; Nolan BE; Albrecht AV; Xhani S; Sun D; Demaree B; Pillarisetti P; Khanna C; Wright F; Chen PA; Yoon S; Stiegler AL; Maurer K; Garifallou JP; Rymaszewski A; Kroft SH; Olson TS; Seif AE; Wertheim G; Grant SFA; Vo LT; Puck JM; Sullivan KE; Routes JM; Zakharova V; Shcherbina A; Mukhina A; Rudy NL; Hurst ACE; Atkinson TP; Boggon TJ; Hakonarson H; Abate AR; Hajjar J; Nicholas SK; Lupski JR; Verbsky J; Chinn IK; Gonzalez MV; Wells AD; Marson A; Poon GMK; Romberg N
    J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33951726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.
    Szutorisz H; Canzonetta C; Georgiou A; Chow CM; Tora L; Dillon N
    Mol Cell Biol; 2005 Mar; 25(5):1804-20. PubMed ID: 15713636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.
    Su GH; Chen HM; Muthusamy N; Garrett-Sinha LA; Baunoch D; Tenen DG; Simon MC
    EMBO J; 1997 Dec; 16(23):7118-29. PubMed ID: 9384589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.
    Yashiro T; Kubo M; Ogawa H; Okumura K; Nishiyama C
    PLoS One; 2015; 10(9):e0137699. PubMed ID: 26361334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo DNA Methyltransferases Dnmt3a and Dnmt3b regulate the onset of Igκ light chain rearrangement during early B-cell development.
    Manoharan A; Du Roure C; Rolink AG; Matthias P
    Eur J Immunol; 2015 Aug; 45(8):2343-55. PubMed ID: 26059604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.
    Lazorchak AS; Schlissel MS; Zhuang Y
    Mol Cell Biol; 2006 Feb; 26(3):810-21. PubMed ID: 16428437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding.
    Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E
    Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
    Weigelt K; Ernst W; Walczak Y; Ebert S; Loenhardt T; Klug M; Rehli M; Weber BH; Langmann T
    J Leukoc Biol; 2007 Dec; 82(6):1564-74. PubMed ID: 17827340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.